Lucy Shapiro, Director at Anacor Pharmaceuticals, Inc. (ANAC), sold 25,000 shares at $8.04 ($200K) on 2013-04-19, disclosed to the SEC on 2013-04-19.
Scheduled sale ($200k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.98 | 10,000 | $80K | 39.8% |
| 2 | $8.04 | 15,000 | $121K | 60.2% |
| Total | $8.02 avg | 25,000 | $200K | 100% |
| Filing → |
| ANAC | SELL | 2014-03-25 | $1.7M | — | Filing → |
| ANAC | SELL | 2013-03-22 | $138K | — | Filing → |
| ANAC | SELL | 2012-10-05 | $200K | — | Filing → |